Back to Search
Start Over
Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-STelevation Myocardial Infarction) programme
- Source :
- European Heart Journal, European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (13), pp.1063-1071. ⟨10.1093/eurheartj/ehv567⟩, European Heart Journal, 2016, 37 (13), pp.1063-1071. ⟨10.1093/eurheartj/ehv567⟩
- Publication Year :
- 2016
- Publisher :
- HAL CCSD, 2016.
-
Abstract
- Aims The use of opioids is recommended for pain relief in patients with myocardial infarction (MI) but may delay antiplatelet agent absorption, potentially leading to decreased treatment efficacy. Methods and results In-hospital complications (death, non-fatal re-MI, stroke, stent thrombosis, and bleeding) and 1-year survival according to pre-hospital morphine use were assessed in 2438 ST-elevation MI (STEMI) patients from the French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2010. The analyses were replicated in the 1726 STEMI patients of the FAST-MI 2005 cohort, in which polymorphisms of CYP2C19 and ABCB1 had been assessed. Specific subgroup analyses taking into account these genetic polymorphisms were performed in patients pre-treated with thienopyridines. The 453 patients (19%) receiving morphine pre-hospital were younger, more often male, with a lower GRACE score and higher chest pain levels. After adjustment for baseline differences, in-hospital complications and 1-year survival (hazard ratio = 0.69; 95% confidence interval: 0.35–1.37) were not increased according to pre-hospital morphine use. After propensity score matching, 1-year survival according to pre-hospital morphine was also similar. Consistent results were found in the replication cohort, including in those receiving pre-hospital thienopyridines and whatever the genetic polymorphisms of CYP2C19 and ABCB1. Conclusion In two independent everyday-life cohorts, pre-hospital morphine use in STEMI patients was not associated with worse in-hospital complications and 1-year mortality. Clinical trial registration Clinicaltrials.gov identifier: [NCT00673036][1] (FAST-MI 2005); [NCT01237418][2] (FAST-MI 2010). [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00673036&atom=%2Fehj%2F37%2F13%2F1063.atom [2]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT01237418&atom=%2Fehj%2F37%2F13%2F1063.atom
- Subjects :
- Male
Emergency Medical Services
medicine.medical_specialty
ATP Binding Cassette Transporter, Subfamily B
Pain
Acute myocardial infarction
030204 cardiovascular system & hematology
Chest pain
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
medicine
Humans
Drug Interactions
Registries
030212 general & internal medicine
Myocardial infarction
Non-ST Elevated Myocardial Infarction
Stroke
Aged
Polymorphism, Genetic
Morphine
business.industry
ST elevation
Hazard ratio
Middle Aged
medicine.disease
3. Good health
Analgesics, Opioid
Cytochrome P-450 CYP2C19
Hospitalization
Opioids
Treatment Outcome
ST-elevation myocardial infarction
Cohort
Propensity score matching
Cardiology
ST Elevation Myocardial Infarction
Platelet aggregation inhibitor
Female
France
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Platelet Aggregation Inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 0195668X and 15229645
- Database :
- OpenAIRE
- Journal :
- European Heart Journal, European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (13), pp.1063-1071. ⟨10.1093/eurheartj/ehv567⟩, European Heart Journal, 2016, 37 (13), pp.1063-1071. ⟨10.1093/eurheartj/ehv567⟩
- Accession number :
- edsair.doi.dedup.....f04d3c2a70684bebe771c0ecf2a31db6